Ming‐Yu Yang

7.4k total citations · 1 hit paper
149 papers, 4.2k citations indexed

About

Ming‐Yu Yang is a scholar working on Molecular Biology, Endocrine and Autonomic Systems and Physiology. According to data from OpenAlex, Ming‐Yu Yang has authored 149 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 20 papers in Endocrine and Autonomic Systems and 20 papers in Physiology. Recurrent topics in Ming‐Yu Yang's work include Circadian rhythm and melatonin (19 papers), Acute Myeloid Leukemia Research (10 papers) and MicroRNA in disease regulation (9 papers). Ming‐Yu Yang is often cited by papers focused on Circadian rhythm and melatonin (19 papers), Acute Myeloid Leukemia Research (10 papers) and MicroRNA in disease regulation (9 papers). Ming‐Yu Yang collaborates with scholars based in Taiwan, China and United States. Ming‐Yu Yang's co-authors include Sheng‐Fung Lin, Pai‐Mei Lin, Cheng‐Ming Hsu, Xinglong Wu, Jie Yan, Ming Li, Fuchou Tang, Jun Wu, Hongshan Guo and Jin Huang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Ming‐Yu Yang

139 papers receiving 4.1k citations

Hit Papers

Single-cell RNA-Seq profiling of human preimplantation em... 2013 2026 2017 2021 2013 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming‐Yu Yang Taiwan 31 2.1k 651 620 469 331 149 4.2k
Stéphane Brézillon France 31 3.0k 1.4× 621 1.0× 541 0.9× 772 1.6× 520 1.6× 60 6.1k
Ofer Reizes United States 30 3.1k 1.5× 725 1.1× 364 0.6× 440 0.9× 894 2.7× 86 5.4k
Yun Lu United States 37 2.7k 1.3× 662 1.0× 377 0.6× 449 1.0× 636 1.9× 109 5.4k
Ning Sun China 38 5.3k 2.5× 784 1.2× 329 0.5× 633 1.3× 279 0.8× 151 7.5k
Min Chen China 32 2.4k 1.2× 993 1.5× 193 0.3× 316 0.7× 587 1.8× 157 4.2k
Marc Schmidt Germany 32 2.0k 1.0× 321 0.5× 272 0.4× 737 1.6× 331 1.0× 58 4.1k
Seyun Kim South Korea 27 2.2k 1.1× 185 0.3× 324 0.5× 573 1.2× 233 0.7× 76 4.4k
Martina Schmidt Netherlands 45 4.2k 2.0× 330 0.5× 200 0.3× 1.0k 2.1× 487 1.5× 240 6.9k

Countries citing papers authored by Ming‐Yu Yang

Since Specialization
Citations

This map shows the geographic impact of Ming‐Yu Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming‐Yu Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming‐Yu Yang more than expected).

Fields of papers citing papers by Ming‐Yu Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming‐Yu Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming‐Yu Yang. The network helps show where Ming‐Yu Yang may publish in the future.

Co-authorship network of co-authors of Ming‐Yu Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Ming‐Yu Yang. A scholar is included among the top collaborators of Ming‐Yu Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming‐Yu Yang. Ming‐Yu Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Ming‐Yu, et al.. (2025). Chronic low-dose REV-ERBs agonist SR9009 mitigates constant light-induced weight gain and insulin resistance via adipogenesis modulation. Biomedical Journal. 48(3). 100830–100830. 2 indexed citations
2.
Wu, Shao‐Chun, Cheng‐Shyuan Rau, Yi-Chan Wu, et al.. (2025). Single-cell transcriptomic analysis reveals therapeutic mechanisms of adipose-derived stem cell exosomes in sepsis-induced lung injury. International Journal of Surgery. 111(12). 9049–9064.
3.
Jiang, Bo, Ying Guo, Ming‐Yu Yang, et al.. (2024). The analgesic effect of continuous adductor canal block combined with popliteal plexus block for total knee arthroplasty: a randomized controlled trial. Scientific Reports. 14(1). 27757–27757. 3 indexed citations
4.
Yang, Ming‐Yu, et al.. (2023). Implication of Ferroptosis in Cholangiocarcinoma: A Potential Future Target?. Cancer Management and Research. Volume 15. 335–342. 6 indexed citations
5.
Zhang, Daqi, Cheng Wang, Kunlin Li, et al.. (2023). Robotic bilateral axillo-breast versus endoscopic bilateral areola thyroidectomy outcomes of 757 patients. Frontiers in Endocrinology. 13. 1029845–1029845. 7 indexed citations
6.
Deng, Jie, Hong‐Hong Yan, Ming‐Yu Yang, et al.. (2023). WS02.13 PD-L1 Expression Guidance on Sintilimab versus Pembrolizumab in Untreated Advanced NSCLC (CTONG1901). Journal of Thoracic Oncology. 18(11). S38–S39. 1 indexed citations
7.
Yang, Ming‐Yu, et al.. (2023). Bibliometric analysis of the current status and trends on medical hyperspectral imaging. Frontiers in Medicine. 10. 1235955–1235955. 3 indexed citations
8.
Ren, Weicheng, Hui Wan, Mattias Berglund, et al.. (2023). Genetic and transcriptomic analyses of diffuse large B-cell lymphoma patients with poor outcomes within two years of diagnosis. Leukemia. 38(3). 610–620. 9 indexed citations
9.
Yang, Chao‐Hui, et al.. (2023). Functional and Molecular Markers for Hearing Loss and Vertigo Attacks in Meniere’s Disease. International Journal of Molecular Sciences. 24(3). 2504–2504. 13 indexed citations
10.
Pei, Jian, Yitong Huang, Qingbin Jiao, et al.. (2023). A Two-Step Simulated Annealing Algorithm for Spectral Data Feature Extraction. Sensors. 23(2). 893–893. 3 indexed citations
11.
Hsu, Cheng‐Ming, et al.. (2022). Down-regulation ofAMPD3Is Associated With Poor Survival in Head and Neck Squamous Cell Carcinoma. In Vivo. 36(2). 704–712. 3 indexed citations
12.
Tsai, Yao‐Te, Ming‐Shao Tsai, Geng‐He Chang, et al.. (2020). Patient-Related Factors of Medialization Laryngoplasty with Autologous Thyroid Cartilage. Healthcare. 8(4). 521–521. 4 indexed citations
13.
Guo, Huijun, Wei Tong, Wei Li, et al.. (2020). [Survival status and influencing factors of HIV/AIDS cases in Liuzhou, 2008-2018].. PubMed. 41(12). 2098–2103. 3 indexed citations
14.
Zhao, Yanyan, et al.. (2020). 1805P Apatinib combined with irinotecan in the treatment of small cell lung cancer: A phase II, single-arm, prospective study. Annals of Oncology. 31. S1043–S1043. 2 indexed citations
15.
Yang, Ming‐Yu, et al.. (2017). The speed of convergence to market efficiency on NASDAQ hedging stocks. Investment Management and Financial Innovations. 10(2). 1 indexed citations
16.
Xia, Lin, et al.. (2015). Comparison of the utility and applicability of the Sokal, Hasford, and EUTOS scores in a population of Chinese patients with chronic-phase chronic myeloid leukemia undergoing imatinib therapy. SHILAP Revista de lepidopterología. 5 indexed citations
17.
Yang, Ming‐Yu, Pai‐Mei Lin, Hui‐Hua Hsiao, et al.. (2015). Up-regulation of PER3 Expression Is Correlated with Better Clinical Outcome in Acute Leukemia.. PubMed. 35(12). 6615–22. 22 indexed citations
18.
Han, Gang, Yan Wang, Wenzhi Bi, et al.. (2015). Reconstruction using massive allografts after resection of extremity osteosarcomas the study design: A retrospective cohort study. International Journal of Surgery. 21. 108–111. 18 indexed citations
19.
Yang, Ming‐Yu, Jan‐Gowth Chang, Pai‐Mei Lin, et al.. (2006). Downregulation of circadian clock genes in chronic myeloid leukemia: Alternative methylation pattern of hPER3. Cancer Science. 97(12). 1298–1307. 103 indexed citations
20.
Chen, Rong‐Fu, et al.. (2001). A model of the real-time correlation of viral titers with immune reactions in antibody-dependent enhancement of dengue-2 infections. FEMS Immunology & Medical Microbiology. 30(1). 1–7. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026